Aandelen in “Fabricage van farmaceutische preparaten”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Calithera Biosciences Inc |
29/01 | 0,001 USD
-88,00% |
-88,00% |
|
Can-Fite Biopharma Ltd |
4/02 | 1,390 USD
-4,79% |
-4,79% |
|
Capricor Therapeutics Inc |
4/02 | 15,070 USD
-0,72% |
-0,72% |
|
Cara Therapeutics Inc |
4/02 | 4,910 USD
+2,72% |
+2,72% |
|
Carisma Therapeutics, Inc. |
4/02 | 0,464 USD
+1,53% |
+1,53% |
|
Cassava Sciences Inc |
4/02 | 2,390 USD
+1,27% |
+1,27% |
|
Catalent Inc. |
17/12 | 63,480 USD
0,00% |
0,00% |
|
Catalyst Pharmaceuticals Inc |
4/02 | 23,090 USD
+2,08% |
+2,08% |
|
Cellectar Biosciences Inc |
4/02 | 0,260 USD
-0,76% |
-0,76% |
Celyad Oncology |
4/02 | 0,430 EUR
0,00% |
0,00% |
|
Chimerix Inc |
4/02 | 3,930 USD
+3,42% |
+3,42% |
|
China Pharma Holdings Inc. |
4/02 | 0,206 USD
-7,63% |
-7,63% |
|
Clearside Biomedical Inc |
4/02 | 0,978 USD
+4,09% |
+4,09% |
|
Cns Pharmaceuticals Inc |
4/02 | 0,097 USD
+0,83% |
+0,83% |
|
Cocrystal Pharma Inc |
4/02 | 1,970 USD
+5,35% |
+5,35% |
|
Cogent Biosciences Inc |
4/02 | 9,250 USD
+2,89% |
+2,89% |
|
Collegium Pharmaceutical Inc |
4/02 | 30,930 USD
-0,87% |
-0,87% |
|
Corbus Pharmaceuticals Holdings Inc |
4/02 | 9,650 USD
+1,47% |
+1,47% |
|
Corcept Therapeutics Inc |
4/02 | 66,910 USD
+0,54% |
+0,54% |
|
CorMedix Inc |
4/02 | 10,480 USD
+6,29% |
+6,29% |
|
Corvus Pharmaceuticals Inc |
4/02 | 5,340 USD
+5,33% |
+5,33% |
|
Cumberland Pharmaceuticals Inc. |
4/02 | 3,760 USD
+76,53% |
+76,53% |
|
Cyclacel Pharmaceuticals Inc |
4/02 | 6,750 USD
-2,17% |
-2,17% |
|
Cyclacel Pharmaceuticals Inc |
4/02 | 0,350 USD
+0,69% |
+0,69% |
|
Cytokinetics Inc |
4/02 | 49,200 USD
+1,52% |
+1,52% |
|
CytomX Therapeutics Inc |
4/02 | 0,864 USD
+2,83% |
+2,83% |
Nieuws over “Fabricage van farmaceutische preparaten”
